TWD 22.35
(-1.76%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.08 Million TWD | 1.22% |
2022 | 72.75 Million TWD | 7.16% |
2021 | 67.9 Million TWD | 4.3% |
2020 | 65.1 Million TWD | 190.27% |
2019 | -72.11 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 38.61 Million TWD | 14.13% |
2023 Q4 | 33.83 Million TWD | 7.14% |
2023 Q2 | 31.57 Million TWD | 9.37% |
2023 FY | 73.64 Million TWD | 1.22% |
2022 FY | 72.75 Million TWD | 7.16% |
2022 Q4 | 28.86 Million TWD | 0.0% |
2021 FY | 67.9 Million TWD | 4.3% |
2020 FY | 65.1 Million TWD | 190.27% |
2019 FY | -72.11 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 99.152% |
Level Biotechnology Inc. | 151.99 Million TWD | 99.287% |
Sagittarius Life Science Corp | 135.85 Million TWD | 99.203% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 98.572% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.519% |
GlycoNex Incorporation | 995 Thousand TWD | -8.844% |
VBI | 32.55 Million TWD | 96.673% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 99.578% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 99.442% |
Visgeneer Inc. | 67.48 Million TWD | 98.395% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.289% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 99.788% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 98.305% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.925% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 96.31% |
Enimmune corporation | 220.1 Million TWD | 99.508% |
TaiRx, Inc. | 217.13 Million TWD | 99.501% |
CHO Pharma, Inc. | 268.99 Million TWD | 99.597% |
EirGenix Inc. | 236.74 Million TWD | 99.543% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 98.962% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 99.697% |
Lin BioScience, Inc. | 1.09 Billion TWD | 99.901% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 99.593% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 97.811% |
Lukas Biomedical Inc. | 177.45 Million TWD | 99.39% |
RBC Bioscience Corporation | 58.35 Million TWD | 98.144% |
BiOptic Inc. | 108.69 Million TWD | 99.004% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -1103.333% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 98.438% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 58.585% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.832% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -229.179% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 97.647% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.097% |
Neith Corporation | 66.87 Million TWD | 98.381% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 98.84% |
NaviFUS Corp. | 11.82 Million TWD | 90.843% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 99.432% |
Sinew Pharma Inc. | 186.25 Million TWD | 99.419% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 98.537% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 99.509% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 97.389% |
AP Biosciences Inc | 32.25 Million TWD | 96.642% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.941% |
3D Global Biotech Inc. | 5.27 Million TWD | 79.465% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 99.659% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.66% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 99.904% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 97.389% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 99.361% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 99.263% |
TCI GENE Inc. | 174.61 Million TWD | 99.38% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -5916.667% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 99.64% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 99.628% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 98.71% |
PharmaEngine, Inc. | 441.78 Million TWD | 99.755% |
Savior Lifetec Corporation | 223.36 Million TWD | 99.515% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 99.581% |
OBI Pharma, Inc. | 2.01 Billion TWD | 99.946% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.22% |
Acepodia, Inc. | 452.56 Million TWD | 99.761% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 99.8% |